Across the pharmaceutical industry, quality failures rarely occur because procedures are missing. They happen when quality systems are poorly led, inconsistently applied, or treated as a compliance exercise rather than a leadership responsibility.
This white paper explores the critical role of senior leadership in shaping the effectiveness of the Pharmaceutical Quality System (PQS). Drawing on regulatory expectations, inspection trends and real-world observations across GMP organisations, it explains why leadership engagement is the defining factor in quality system maturity and inspection performance.
What you’ll learn
Download this white paper to learn:
- Why PQS failures are often leadership failures rather than technical problems.
- What regulators expect from senior management under ICH Q10 and EU GMP Chapter 1.
- How inspection data highlights leadership accountability in quality system effectiveness.
- The leadership behaviours that drive stronger Quality Management Maturity (QMM).
- Practical ways to strengthen leadership engagement in quality governance.
Who should read this
- This white paper is designed for:
- Senior leadership in pharmaceutical and biotech organisations.
- Quality Assurance and Regulatory leaders.
- Manufacturing and operations executives responsible for GMP compliance.
- Organisations seeking to improve inspection readiness and quality maturity.
Click here to download the full white paper
